menu
    • menu
    [{"orgOrder":0,"company":"Uni-Pharma SA","sponsor":"Attikon Hospital","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"GREECE","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Liothyronine Sodium","moa":"Thyroid hormone receptor","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"Uni-Pharma SA","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Intravenous Injection","sponsorNew":"Uni-Pharma SA \/ Attikon Hospital","highestDevelopmentStatusID":"8","companyTruncated":"Uni-Pharma SA \/ Attikon Hospital"},{"orgOrder":0,"company":"Uni-Pharma SA","sponsor":"Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"GREECE","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Chloroquine Phosphate","moa":"Ferriprotoporphyrin IX","graph1":"Infections and Infectious Diseases","graph2":"Phase II","graph3":"Uni-Pharma SA","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Uni-Pharma SA \/ Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini","highestDevelopmentStatusID":"8","companyTruncated":"Uni-Pharma SA \/ Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini"}]

    Find Clinical Drug Pipeline Developments & Deals by Uni-Pharma SA

    Menu

    Uni-Pharma SA

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Liothyronine Sodium

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Study Phase : Phase II

                            Sponsor : Attikon Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            April 16, 2020

                            Lead Product(s) : Liothyronine Sodium

                            Therapeutic Area : Pulmonary/Respiratory Diseases

                            Highest Development Status : Phase II

                            Sponsor : Attikon Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Chloroquine Phosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase II

                            Sponsor : Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, N...

                            Details : Undisclosed

                            Product Name : Unikinon

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            April 14, 2020

                            Lead Product(s) : Chloroquine Phosphate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase II

                            Sponsor : Athens General Hospital Hippokrateio | Sotiria Thoracic Diseases Hospital | Sismanoglio General Hospital | Divine Providence Hospital Pammakaristos | AHEPA University Hospital | University Hospital of Ioannina | Corfu General Hospital Agia Irini

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Ferrous Sulfate

                            Therapeutic Area : Hematology

                            Study Phase : Phase IV

                            Sponsor : Attikon Hospital | Amalia Fleming Prefecture General Hospital of Melissia | G.Gennimatas General Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Ferrous Acetyl-Aspartate Casein Formulation Evaluation Over Ferrous Sulfate in Iron Deficiency Anemia

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Vitamins/Minerals/Inorganic Salts

                            Upfront Cash : Inapplicable

                            May 15, 2018

                            Lead Product(s) : Ferrous Sulfate

                            Therapeutic Area : Hematology

                            Highest Development Status : Phase IV

                            Sponsor : Attikon Hospital | Amalia Fleming Prefecture General Hospital of Melissia | G.Gennimatas General Hospital

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed

                            Uni-Pharma SA

                            Greece arrow
                            EPSC
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Paracetamol

                            Therapeutic Area : Immunology

                            Study Phase : Phase IV

                            Sponsor : Attikon Hospital | University Hospital of Patras | University Hospital of Crete | Thriasio General Hospital of Elefsina | General Hospital of Thessaloniki Ippokratio | General Hospital of Chalkida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A New Formulation of Intravenous Paracetamol for Fever Management

                            Details : Undisclosed

                            Product Name : Undisclosed

                            Product Type : Other Small Molecule

                            Upfront Cash : Inapplicable

                            November 05, 2014

                            Lead Product(s) : Paracetamol

                            Therapeutic Area : Immunology

                            Highest Development Status : Phase IV

                            Sponsor : Attikon Hospital | University Hospital of Patras | University Hospital of Crete | Thriasio General Hospital of Elefsina | General Hospital of Thessaloniki Ippokratio | General Hospital of Chalkida

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth